Invesco
ONCS

Invesco’s OncoSec Medical Incorporated ONCS Stock Holding History

Invesco’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-60
Closed -$8K – 3919
2018
Q4 		$8K Buy
60
+2
+3% +$502 ﹤0.01% 3787
2018
Q3 		$18K Buy
+58
New +$17.8K ﹤0.01% 3850

Other funds holding ONCS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Invesco's ONCS Position: Q1 2019 in Review

Invesco sold out of OncoSec Medical Incorporated (ONCS) in Q1 2019, closing a stake of 60 shares — an estimated $8K sold.

Invesco first reported a position in ONCS in Q3 2018 and held it in 2 quarters. The position peaked at $18K in Q3 2018. 30 funds tracked by Wall St. Rank hold ONCS as of Q1 2019.

  • Invesco reported no remaining OncoSec Medical Incorporated position as of Q1 2019 after selling out during the quarter.
  • Invesco sold 60 OncoSec Medical Incorporated shares in Q1 2019, an estimated $8K.
  • Invesco first reported a position in OncoSec Medical Incorporated in Q3 2018 and held it in 2 quarters.
  • Invesco's OncoSec Medical Incorporated position peaked at $18K in Q3 2018.
  • 30 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2019.

Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.